Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Metabolite of previously reported compound acts as potent, selective 5-HT4 receptor antagonist

July 9, 1999

Maxim updates Maxamine clinical trial program

July 8, 1999

Astra (AstraZeneca) presents new agents for GI inflammatory disorders

July 5, 1999

Howard Hughes researchers uncover mechanism of interferon resistance in HCV

July 5, 1999

Naturally occurring anti-H. pylori substances discovered by Takeda

July 2, 1999

Relief in sight for female patients with IBS: Glaxo Wellcome files NDA for alosetron

July 1, 1999

Shiseido describes new gastric antisecretory agents for ulcers

June 30, 1999

Enzon and Schering-Plough revise agreement for PEG-Intron

June 30, 1999

Antiinflammatory mechanism(s) of orazipone undergoes study at Orion

June 29, 1999

Immunex renews gene license with Digital Gene Technologies

June 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...